These results suggest that ART enhances the ability of ENZ to inhibit AR-driven pathways and induce apoptosis in ENZ-R PCa cells, thus providing a strong rationale for using ART in combination with ENZ to improve therapeutic outcomes in patients with drug-resistant PCa. The gene discussed is AR; the disease is posterior cortical atrophy.